Skip to content

The Effect of Different Food Products on Post Prandial Blood Glucose in Pregnant Woman With Diabetes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02154997
Enrollment
100
Registered
2014-06-04
Start date
2014-11-30
Completion date
2017-12-31
Last updated
2016-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Type 1 Diabetes, Type 2 Diabetes

Brief summary

During pregnancy nutrition demands change and the pregnant woman needs to adjust her food intake and take into consideration the corrected daily recommendations for micro and macro nutrients. Pregnant woman tend to suffer from hyperemesis and this affects their food choice. Amongst pregnant women with Diabetes the glucose balance is extremely important during pregnancy. Glucose balance is a result of correct nutrition and an exact amount of insulin. This delicate balance requires from the pregnant women an ability to perform correct carbohydrate count. Hyperglycemia has already been proven to affect the fetus and the neonatal outcomes. Hypoglycemia may also have a negative effect but the main danger is immediate harm to the mother and therefore to the fetus. For those reasons glucose balance is crucial and demands delicate synchronization of nutrition and insulin therapy.

Interventions

None listed

Sponsors

Uri Elchalal
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-45 * women who suffer from type 1 diabetes, type 2 diabetes or gestational diabetes * Do not suffer from any intestinal disease * Accept to sign a consent form

Exclusion criteria

* over age of 45 * under age of 18 * suffer from any intestinal disease * do not accept to sign a consent form

Design outcomes

Primary

MeasureTime frameDescription
Post prandial blood glucose levelsThe outcome will be measured at various time points during a 120 min OGTT: Fasting, 30, 60, 90 and 120 minFor every time point blood glucose will be analyzed for blood glucose and for Insulin and C-peptide for the control group

Countries

Israel

Contacts

Primary ContactUriel Elchalal, MD
uriel@hadassah.org.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026